These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The impact of chemotherapy in germ cell tumours. Kaye SB; Boyle P Cancer Surv; 1989; 8(3):631-46. PubMed ID: 2561756 [TBL] [Abstract][Full Text] [Related]
8. Testicular germ cell tumors. An update on clinical pathologic correlation. Abu-Jawdeh GM; Oyasu R Acta Pathol Jpn; 1991 Feb; 41(2):83-93. PubMed ID: 1645924 [No Abstract] [Full Text] [Related]
9. [The role of chemotherapy in the treatment of testicular cancer with the exception of seminomas]. Kenis Y; Piccart M; Beer M Rev Med Brux; 1983 Apr; 4(4):219-23. PubMed ID: 6192477 [No Abstract] [Full Text] [Related]
10. Alternatives to standard BEP x 3 in good-prognosis germ cell tumors--you bet your life. Nichols C; Kollmannsberger C J Natl Cancer Inst; 2010 Aug; 102(16):1214-5. PubMed ID: 20631340 [No Abstract] [Full Text] [Related]
11. Re: Nicola Nicolai, Rosalba Miceli, Andrea Necchi, et al. Retroperitoneal lymph node dissection with no adjuvant chemotherapy in clinical stage I nonseminomatous germ cell tumours: long-term outcome and analysis of risk factors of recurrence. Eur Urol 2010;58:912-8. Akyol I; Soydan H; Ates F Eur Urol; 2011 Apr; 59(4):e20; author reply e21-2. PubMed ID: 21255907 [No Abstract] [Full Text] [Related]
12. [Tumors of ovary and testis (author's transl)]. De Jager R Rev Med Brux; 1980 May; 1(5):315-20. PubMed ID: 6258206 [No Abstract] [Full Text] [Related]
13. Phase II trial of mitoxantrone in refractory germ cell tumors: a trial of the Southeastern Cancer Study Group. Williams SD; Birch R; Gams R; Irwin L Cancer Treat Rep; 1985 Dec; 69(12):1455-6. PubMed ID: 3000593 [No Abstract] [Full Text] [Related]
14. [Testicular cancer. Standard management leads to recovery in 90 to 95 percent of the cases]. Berger N; Droz JP Rev Prat; 2007 Feb; 57(4):361-3. PubMed ID: 17455737 [No Abstract] [Full Text] [Related]
15. Treatment outcome of metastatic testicular cancer at a single institution in Japan, a country with low incidence of germ cell tumor. Kawai K; Hinotsu S; Oikawa T; Sekido N; Hattori K; Miyanaga N; Hasegawa Y; Kojima H; Shimazui T; Akaza H Jpn J Clin Oncol; 2006 Nov; 36(11):723-30. PubMed ID: 17082218 [TBL] [Abstract][Full Text] [Related]
20. Phase II evaluation of iproplatin in refractory germ cell tumors: a Southeastern Cancer Study Group trial. Drasga RE; Williams SD; Einhorn LH; Birch R Cancer Treat Rep; 1987 Sep; 71(9):863-4. PubMed ID: 3040247 [No Abstract] [Full Text] [Related] [Next] [New Search]